Success Metrics

Clinical Success Rate

88.9%

Based on 8 completed trials

Completion Rate

89%(8/9)

Active Trials

0(0%)

Results Posted

88%(7 trials)

Terminated

1(10%)

Phase Distribution

Ph phase_1

50%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

5(55.6%)

Phase 2Efficacy & side effects

4(44.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Terminated(1)

Other(1)

Detailed Status

Completed8

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

88.9%

Most Advanced

Phase 2

Trials by Phase

Phase 15 (55.6%)

Phase 24 (44.4%)

Trials by Status

terminated110%

unknown110%

completed880%

Recent Activity

0 active trials

Showing 5 of 10

completedphase_1

Clinical Trials (10)

Showing 10 of 10 trials

NCT05485012Phase 1

Reinforcing Effects of Marijuana and Opioids

Completed

NCT01964404Phase 1

Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

Completed

NCT05114460Phase 2

Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal

Terminated

NCT03699540Phase 1

Marijuana Effects on Simulated Driving Performance

Completed

NCT03253926Phase 1

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

Completed

NCT03546790Phase 1

Laboratory Smoking of Marijuana "Blunts"

Completed

NCT02735954

Colorado Marijuana Users Health Cohort

Unknown

NCT00743366Phase 2

Effect of Quetiapine on Marijuana Withdrawal and Relapse

Completed

NCT00373295Phase 2

Effect of Baclofen on Marijuana Withdrawal and Relapse

Completed

NCT00373503Phase 2

Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse

Completed

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10